ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including ...
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
Wave Life Sciences (NASDAQ:WVE) announced clinical trial application approval and initiation of the Phase 1 INLIGHT clinical ...
Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...
GlobalData on MSN1d
Cumberland Pharmaceuticals reports data from trial of ifetroban for DMDCumberland Pharmaceuticals has reported positive outcomes from a trial of ifetroban as a potential treatment for Duchenne ...
Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that Cohort 3 of its Phase 1 clinical trial ...
WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new ...
GlobalData on MSN2d
PhaseV and Alimentiv to support execution of adaptive clinical trials for GIPhaseV has formed a strategic collaboration with Alimentiv for supporting the design and execution of adaptive clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback